Emerging and investigational therapies for neuroblastoma.

about

Emerging and investigational therapies for neuroblastoma.

Item

http://www.wikidata.org/entity/Q50073387

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Emerging and investigational therapies for neuroblastoma.

@en

Emerging and investigational therapies for neuroblastoma.

@nl

type

Item

label

Emerging and investigational therapies for neuroblastoma.

@en

Emerging and investigational therapies for neuroblastoma.

@nl

prefLabel

Emerging and investigational therapies for neuroblastoma.

@en

Emerging and investigational therapies for neuroblastoma.

@nl

P1476

Emerging and investigational therapies for neuroblastoma

@en

P2093

Ami V Desai

http://www.w3.org/2001/XMLSchema#string

Mark A Applebaum

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

Outcome after reduced chemotherapy for intermediate-risk neuroblastoma

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

In silico Driven Redesign of a Clinically Relevant Antibody for the Treatment of GD2 Positive Tumors

BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models

The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non-Small Cell Lung Cancer

Activating mutations in ALK provide a therapeutic target in neuroblastoma.

Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma.

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.

Dabrafenib and trametinib, alone and in combination for BRAF-mutant metastatic melanoma.

P304

355-368

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21678707.2017.1304212

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Susan L. Cohn

Julia L Glade Bender

P577

2017-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29062613

http://www.w3.org/2001/XMLSchema#string

P932

5649635

http://www.w3.org/2001/XMLSchema#string